{
  "subtype_biology": {
    "SCLC_A": {
      "name": "SCLC-A (ASCL1-high)",
      "biology": "Classical neuroendocrine, high DLL3, MYC-driven proliferation",
      "key_genes": [
        "ASCL1",
        "DLL3",
        "MYC",
        "AURKA",
        "BCL2",
        "NOTCH1",
        "SOX2"
      ],
      "vulnerabilities": [
        "DLL3 surface expression \u2192 Rovalpituzumab tesirine (Rova-T)",
        "BCL2 overexpression \u2192 BCL2 inhibitors (venetoclax)",
        "Aurora kinase dependency \u2192 AURKA inhibitors (alisertib)",
        "Notch pathway inactive \u2192 DLL3-targeting ADCs",
        "High proliferation \u2192 Topoisomerase inhibitors (lurbinectedin)"
      ],
      "recommended_drugs": [
        [
          "Rovalpituzumab tesirine",
          "DLL3-targeting ADC",
          "Phase III completed"
        ],
        [
          "Alisertib",
          "Aurora A inhibitor",
          "Phase II"
        ],
        [
          "Venetoclax",
          "BCL2 inhibitor",
          "Phase I/II"
        ],
        [
          "Lurbinectedin",
          "Transcription inhibitor",
          "FDA approved"
        ],
        [
          "Tarlatamab",
          "DLL3xCD3 bispecific",
          "FDA approved 2024"
        ]
      ],
      "metabolic_targets": [
        "OXPHOS",
        "Glutaminolysis"
      ],
      "io_sensitivity": "Low - poor immune infiltration"
    },
    "SCLC_N": {
      "name": "SCLC-N (NEUROD1-high)",
      "biology": "Neuroendocrine variant, MYCN amplification, neural differentiation",
      "key_genes": [
        "NEUROD1",
        "MYCN",
        "AURKA",
        "AURKB",
        "MYC",
        "IGF1R",
        "SOX2"
      ],
      "vulnerabilities": [
        "MYCN amplification \u2192 Aurora kinase inhibitors",
        "MYC/MYCN dependency \u2192 BET inhibitors (JQ1)",
        "IGF1R signaling \u2192 IGF1R inhibitors",
        "High mitotic rate \u2192 PLK1 inhibitors",
        "DNA damage response defects \u2192 PARP inhibitors"
      ],
      "recommended_drugs": [
        [
          "Alisertib",
          "Aurora A inhibitor",
          "Stabilizes MYCN"
        ],
        [
          "Olaparib",
          "PARP inhibitor",
          "DDR defects"
        ],
        [
          "Volasertib",
          "PLK1 inhibitor",
          "Phase II"
        ],
        [
          "JQ1/OTX015",
          "BET inhibitor",
          "Preclinical"
        ],
        [
          "Linsitinib",
          "IGF1R inhibitor",
          "Preclinical"
        ]
      ],
      "metabolic_targets": [
        "OXPHOS",
        "Lipid synthesis"
      ],
      "io_sensitivity": "Low - neuroendocrine phenotype"
    },
    "SCLC_P": {
      "name": "SCLC-P (POU2F3-high)",
      "biology": "Tuft cell-like, non-neuroendocrine, chemoresistant",
      "key_genes": [
        "POU2F3",
        "SOX9",
        "TRPM5",
        "IGF1R",
        "FGFR1",
        "NOTCH1",
        "REST"
      ],
      "vulnerabilities": [
        "IGF1R overexpression \u2192 IGF1R inhibitors",
        "FGFR1 amplification \u2192 FGFR inhibitors (erdafitinib)",
        "Notch pathway active \u2192 Notch inhibitors",
        "Chemoresistant \u2192 Alternative mechanisms needed",
        "Unique tuft cell biology \u2192 Novel targets"
      ],
      "recommended_drugs": [
        [
          "Erdafitinib",
          "FGFR inhibitor",
          "FDA approved other"
        ],
        [
          "Linsitinib",
          "IGF1R inhibitor",
          "Phase II"
        ],
        [
          "Nirogacestat",
          "Gamma-secretase inhibitor",
          "Notch pathway"
        ],
        [
          "Trilaciclib",
          "CDK4/6 inhibitor",
          "Myeloprotection"
        ],
        [
          "Temozolomide",
          "Alkylating agent",
          "Alternative chemo"
        ]
      ],
      "metabolic_targets": [
        "Glycolysis",
        "One-carbon metabolism"
      ],
      "io_sensitivity": "Moderate - variable immune infiltration"
    },
    "SCLC_I": {
      "name": "SCLC-I (Inflamed)",
      "biology": "Low neuroendocrine, high immune infiltration, T-cell inflamed",
      "key_genes": [
        "CD274",
        "PDCD1LG2",
        "IDO1",
        "STAT1",
        "IRF1",
        "HLA-A",
        "CXCL10"
      ],
      "vulnerabilities": [
        "High PD-L1/PD-L2 \u2192 Immune checkpoint inhibitors",
        "T-cell infiltration \u2192 Enhance with anti-CTLA4",
        "IFN-\u03b3 signature \u2192 Biomarker for IO response",
        "Antigen presentation intact \u2192 Tumor vaccines",
        "LAG3/TIGIT expression \u2192 Next-gen checkpoints"
      ],
      "recommended_drugs": [
        [
          "Atezolizumab",
          "PD-L1 inhibitor",
          "FDA approved SCLC"
        ],
        [
          "Durvalumab",
          "PD-L1 inhibitor",
          "FDA approved SCLC"
        ],
        [
          "Ipilimumab",
          "CTLA-4 inhibitor",
          "Combination"
        ],
        [
          "Tiragolumab",
          "TIGIT inhibitor",
          "Phase III"
        ],
        [
          "Relatlimab",
          "LAG-3 inhibitor",
          "Phase II"
        ]
      ],
      "metabolic_targets": [
        "IDO1",
        "Tryptophan metabolism"
      ],
      "io_sensitivity": "High - best IO responders"
    }
  },
  "drug_mappings": {
    "SCLC_A": [
      {
        "drug": "CISPLATIN",
        "targets": [
          "MYC",
          "AURKA",
          "BCL2"
        ],
        "n_targets": 3,
        "score": 2.4849066497880004
      },
      {
        "drug": "ALISERTIB",
        "targets": [
          "MYC",
          "AURKA"
        ],
        "n_targets": 2,
        "score": 2.19722457733622
      },
      {
        "drug": "PACLITAXEL",
        "targets": [
          "AURKA",
          "BCL2"
        ],
        "n_targets": 2,
        "score": 2.079441541679836
      },
      {
        "drug": "CYC-116",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.302585092994046
      },
      {
        "drug": "ILORASERTIB",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.302585092994046
      },
      {
        "drug": "CENISERTIB",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.302585092994046
      },
      {
        "drug": "RG-1530",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.302585092994046
      },
      {
        "drug": "OLAPARIB",
        "targets": [
          "MYC"
        ],
        "n_targets": 1,
        "score": 2.302585092994046
      },
      {
        "drug": "NVP-TAE684",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.19722457733622
      },
      {
        "drug": "GW441756X",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      },
      {
        "drug": "ENTRECTINIB",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      },
      {
        "drug": "IMATINIB",
        "targets": [
          "MYC"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      },
      {
        "drug": "SORAFENIB",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      },
      {
        "drug": "PF-562271",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      },
      {
        "drug": "PAZOPANIB",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      },
      {
        "drug": "HESPERADIN",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 1.9459101490553128
      }
    ],
    "SCLC_N": [
      {
        "drug": "CISPLATIN",
        "targets": [
          "MYCN",
          "MYC",
          "AURKA"
        ],
        "n_targets": 3,
        "score": 2.4849066497880004
      },
      {
        "drug": "ILORASERTIB",
        "targets": [
          "IGF1R",
          "AURKB",
          "AURKA"
        ],
        "n_targets": 3,
        "score": 2.302585092994046
      },
      {
        "drug": "CENISERTIB",
        "targets": [
          "IGF1R",
          "AURKB",
          "AURKA"
        ],
        "n_targets": 3,
        "score": 2.302585092994046
      },
      {
        "drug": "ALISERTIB",
        "targets": [
          "MYC",
          "AURKB",
          "AURKA"
        ],
        "n_targets": 3,
        "score": 2.19722457733622
      },
      {
        "drug": "GW441756X",
        "targets": [
          "AURKB",
          "IGF1R",
          "AURKA"
        ],
        "n_targets": 3,
        "score": 2.079441541679836
      },
      {
        "drug": "ENTRECTINIB",
        "targets": [
          "AURKB",
          "IGF1R",
          "AURKA"
        ],
        "n_targets": 3,
        "score": 2.079441541679836
      },
      {
        "drug": "PF-562271",
        "targets": [
          "AURKB",
          "IGF1R",
          "AURKA"
        ],
        "n_targets": 3,
        "score": 2.079441541679836
      },
      {
        "drug": "PAZOPANIB",
        "targets": [
          "AURKB",
          "IGF1R",
          "AURKA"
        ],
        "n_targets": 3,
        "score": 2.079441541679836
      },
      {
        "drug": "HESPERADIN",
        "targets": [
          "AURKB",
          "IGF1R",
          "AURKA"
        ],
        "n_targets": 3,
        "score": 1.9459101490553128
      },
      {
        "drug": "CYC-116",
        "targets": [
          "AURKB",
          "AURKA"
        ],
        "n_targets": 2,
        "score": 2.302585092994046
      },
      {
        "drug": "OLAPARIB",
        "targets": [
          "MYCN",
          "MYC"
        ],
        "n_targets": 2,
        "score": 2.302585092994046
      },
      {
        "drug": "NVP-TAE684",
        "targets": [
          "AURKB",
          "AURKA"
        ],
        "n_targets": 2,
        "score": 2.19722457733622
      },
      {
        "drug": "SORAFENIB",
        "targets": [
          "AURKB",
          "AURKA"
        ],
        "n_targets": 2,
        "score": 2.079441541679836
      },
      {
        "drug": "PD-0166285",
        "targets": [
          "AURKB",
          "IGF1R"
        ],
        "n_targets": 2,
        "score": 2.079441541679836
      },
      {
        "drug": "RG-1530",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.302585092994046
      },
      {
        "drug": "DOVITINIB",
        "targets": [
          "AURKB"
        ],
        "n_targets": 1,
        "score": 2.19722457733622
      },
      {
        "drug": "TALAZOPARIB",
        "targets": [
          "MYCN"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      },
      {
        "drug": "SP-600125",
        "targets": [
          "AURKB"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      },
      {
        "drug": "IMATINIB",
        "targets": [
          "MYC"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      },
      {
        "drug": "PACLITAXEL",
        "targets": [
          "AURKA"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      }
    ],
    "SCLC_P": [
      {
        "drug": "ILORASERTIB",
        "targets": [
          "FGFR1",
          "IGF1R"
        ],
        "n_targets": 2,
        "score": 2.302585092994046
      },
      {
        "drug": "CENISERTIB",
        "targets": [
          "FGFR1",
          "IGF1R"
        ],
        "n_targets": 2,
        "score": 2.302585092994046
      },
      {
        "drug": "GW441756X",
        "targets": [
          "FGFR1",
          "IGF1R"
        ],
        "n_targets": 2,
        "score": 2.079441541679836
      },
      {
        "drug": "ENTRECTINIB",
        "targets": [
          "FGFR1",
          "IGF1R"
        ],
        "n_targets": 2,
        "score": 2.079441541679836
      },
      {
        "drug": "PF-562271",
        "targets": [
          "FGFR1",
          "IGF1R"
        ],
        "n_targets": 2,
        "score": 2.079441541679836
      },
      {
        "drug": "PD-0166285",
        "targets": [
          "FGFR1",
          "IGF1R"
        ],
        "n_targets": 2,
        "score": 2.079441541679836
      },
      {
        "drug": "PAZOPANIB",
        "targets": [
          "FGFR1",
          "IGF1R"
        ],
        "n_targets": 2,
        "score": 2.079441541679836
      },
      {
        "drug": "HESPERADIN",
        "targets": [
          "FGFR1",
          "IGF1R"
        ],
        "n_targets": 2,
        "score": 1.9459101490553128
      },
      {
        "drug": "CISPLATIN",
        "targets": [
          "FGFR1"
        ],
        "n_targets": 1,
        "score": 2.4849066497880004
      },
      {
        "drug": "CYC-116",
        "targets": [
          "FGFR1"
        ],
        "n_targets": 1,
        "score": 2.302585092994046
      },
      {
        "drug": "RG-1530",
        "targets": [
          "FGFR1"
        ],
        "n_targets": 1,
        "score": 2.302585092994046
      },
      {
        "drug": "NVP-TAE684",
        "targets": [
          "FGFR1"
        ],
        "n_targets": 1,
        "score": 2.19722457733622
      },
      {
        "drug": "DOVITINIB",
        "targets": [
          "FGFR1"
        ],
        "n_targets": 1,
        "score": 2.19722457733622
      },
      {
        "drug": "ALISERTIB",
        "targets": [
          "FGFR1"
        ],
        "n_targets": 1,
        "score": 2.19722457733622
      },
      {
        "drug": "SP-600125",
        "targets": [
          "FGFR1"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      },
      {
        "drug": "SORAFENIB",
        "targets": [
          "FGFR1"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      },
      {
        "drug": "PACLITAXEL",
        "targets": [
          "FGFR1"
        ],
        "n_targets": 1,
        "score": 2.079441541679836
      }
    ]
  }
}